MRI-guided cryoablation viable for recurrent prostate cancer

MRI-guided cryoablation viable for recurrent prostate cancer
In men with recurrent prostate cancer following radiation therapy, magnetic resonance imaging-guided focal cryoablation is feasible and seems safe, according to a study published in the August issue of Radiology.

(HealthDay)—In men with recurrent prostate cancer following radiation therapy, magnetic resonance imaging (MRI)-guided focal cryoablation is feasible and seems safe, according to a study published in the August issue of Radiology.

Joyce G.R. Bomers, from Radboud University Nijmegen Medical Centre in the Netherlands, and colleagues studied 10 consecutive patients with histopathologically proved recurrent after , without evidence of distant metastases. While patients were under , a urethral warmer was inserted, followed by transperineal insertion of cryoneedles during real-time MRI and insertion of a rectal warmer. MRI guidance was used to continuously monitor ice ball growth. Two cycles of freezing and thawing were conducted. Follow-up included a urologist visit, prostate-specific antigen level measurement, and multiparametric MRI at three, six, and 12 months.

The researchers found that all patients were successfully treated, although in one patient, the urethral warmer could not be inserted and the procedure was cancelled, but was repeated successfully two months later. Urinary retention was observed in another patient. A local recurrence or remnant tumor was identified at six months in two patients and at 12 months in another patient. Successful retreatment with MRI-guided focal cryoablation occurred in these three patients.

"MR imaging-guided focal cryoablation of recurrent prostate cancer after radiation therapy is feasible and safe," the authors write. "Initial results are promising; however, longer follow-up is needed and more patients must be studied."

One author disclosed to the medical technology industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

PET/MR effective for imaging recurrent prostate cancer

Jun 11, 2013

When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to ...

Recommended for you

Genetics of cancer: Non-coding DNA can finally be decoded

1 hour ago

Cancer is a disease of the genome resulting from a combination of genetic modifications (or mutations). We inherit from our parents strong or weak predispositions to developing certain kinds of cancer; in addition, we also ...

Statin use decreases the risk of Barrett's esophagus

3 hours ago

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the Americ ...

User comments